A citation-based method for searching scientific literature

Catherine H Marshall, Emmanuel S Antonarakis. Curr Opin Oncol 2020
Times Cited: 7







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Johann de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Oliver Sartor, Neeraj Agarwal, David Olmos,[...]. N Engl J Med 2020
601
57

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration.
Wassim Abida, Akash Patnaik, David Campbell, Jeremy Shapiro, Alan H Bryce, Ray McDermott, Brieuc Sautois, Nicholas J Vogelzang, Richard M Bambury, Eric Voog,[...]. J Clin Oncol 2020
190
57

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study.
Wassim Abida, David Campbell, Akash Patnaik, Jeremy D Shapiro, Brieuc Sautois, Nicholas J Vogelzang, Eric G Voog, Alan H Bryce, Ray McDermott, Francesco Ricci,[...]. Clin Cancer Res 2020
156
57

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
819
57


Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.
Jon H Chung, Ninad Dewal, Ethan Sokol, Paul Mathew, Robert Whitehead, Sherri Z Millis, Garrett M Frampton, Gennady Bratslavsky, Sumanta K Pal, Richard J Lee,[...]. JCO Precis Oncol 2019
53
42

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
434
42

Tumour lineage shapes BRCA-mediated phenotypes.
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, Preethi Srinivasan, Shweta S Chavan, Noah D Friedman, Ezra Y Rosen, Allison L Richards, Nancy Bouvier, S Duygu Selcuklu,[...]. Nature 2019
174
28

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Piper Nicolosi, Elisa Ledet, Shan Yang, Scott Michalski, Brandy Freschi, Erin O'Leary, Edward D Esplin, Robert L Nussbaum, Oliver Sartor. JAMA Oncol 2019
135
28

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
J Chad Brenner, Bushra Ateeq, Yong Li, Anastasia K Yocum, Qi Cao, Irfan A Asangani, Sonam Patel, Xiaoju Wang, Hallie Liang, Jindan Yu,[...]. Cancer Cell 2011
317
28

MSH2 Loss in Primary Prostate Cancer.
Liana B Guedes, Emmanuel S Antonarakis, Michael T Schweizer, Nooshin Mirkheshti, Fawaz Almutairi, Jong Chul Park, Stephanie Glavaris, Jessica Hicks, Mario A Eisenberger, Angelo M De Marzo,[...]. Clin Cancer Res 2017
91
28

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.
Catherine H Marshall, Alexandra O Sokolova, Andrea L McNatty, Heather H Cheng, Mario A Eisenberger, Alan H Bryce, Michael T Schweizer, Emmanuel S Antonarakis. Eur Urol 2019
71
28

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.
Mark M Pomerantz, Sandor Spisák, Li Jia, Angel M Cronin, Istvan Csabai, Elisa Ledet, A Oliver Sartor, Irene Rainville, Edward P O'Connor, Zachary T Herbert,[...]. Cancer 2017
152
28

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
Rong Na, S Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz,[...]. Eur Urol 2017
189
28

Integrative genomic profiling of human prostate cancer.
Barry S Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S Carver, Vivek K Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva,[...]. Cancer Cell 2010
28

Pan-cancer whole-genome analyses of metastatic solid tumours.
Peter Priestley, Jonathan Baber, Martijn P Lolkema, Neeltje Steeghs, Ewart de Bruijn, Charles Shale, Korneel Duyvesteyn, Susan Haidari, Arne van Hoeck, Wendy Onstenk,[...]. Nature 2019
303
28

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
James L Mohler, Emmanuel S Antonarakis, Andrew J Armstrong, Anthony V D'Amico, Brian J Davis, Tanya Dorff, James A Eastham, Charles A Enke, Thomas A Farrington, Celestia S Higano,[...]. J Natl Compr Canc Netw 2019
624
28

Pan-cancer landscape of homologous recombination deficiency.
Luan Nguyen, John W M Martens, Arne Van Hoeck, Edwin Cuppen. Nat Commun 2020
94
28

PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer.
Elena Castro, Nuria Romero-Laorden, Angela Del Pozo, Rebeca Lozano, Ana Medina, Javier Puente, Josep Maria Piulats, David Lorente, Maria Isabel Saez, Rafael Morales-Barrera,[...]. J Clin Oncol 2019
153
28

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.
Elena Castro, Chee Goh, Daniel Leongamornlert, Ed Saunders, Malgorzata Tymrakiewicz, Tokhir Dadaev, Koveela Govindasami, Michelle Guy, Steve Ellis, Debra Frost,[...]. Eur Urol 2015
195
28

Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.
Maha Hussain, Stephanie Daignault-Newton, Przemyslaw W Twardowski, Costantine Albany, Mark N Stein, Lakshmi P Kunju, Javed Siddiqui, Yi-Mi Wu, Dan Robinson, Robert J Lonigro,[...]. J Clin Oncol 2018
114
14

Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy.
Priscilla Léon, Geraldine Cancel-Tassin, Sara Drouin, Marie Audouin, Justine Varinot, Eva Comperat, Xavier Cathelineau, François Rozet, Christophe Vaessens, Steven Stone,[...]. World J Urol 2018
13
14

Integrated analysis of germline and somatic variants in ovarian cancer.
Krishna L Kanchi, Kimberly J Johnson, Charles Lu, Michael D McLellan, Mark D M Leiserson, Michael C Wendl, Qunyuan Zhang, Daniel C Koboldt, Mingchao Xie, Cyriac Kandoth,[...]. Nat Commun 2014
190
14

A novel single-cell method provides direct evidence of persistent DNA damage in senescent cells and aged mammalian tissues.
Alessandro Galbiati, Christian Beauséjour, Fabrizio d'Adda di Fagagna. Aging Cell 2017
36
14

Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.
Daniel E Spratt, Mohammed Alshalalfa, Nick Fishbane, Adam B Weiner, Rohit Mehra, Brandon A Mahal, Jonathan Lehrer, Yang Liu, Shuang G Zhao, Corey Speers,[...]. Clin Cancer Res 2019
39
14

Genomic and Clinicopathologic Characterization of ATM-deficient Prostate Cancer.
Harsimar Kaur, Daniela C Salles, Sanjana Murali, Jessica L Hicks, Minh Nguyen, Colin C Pritchard, Angelo M De Marzo, Jerry S Lanchbury, Bruce J Trock, William B Isaacs,[...]. Clin Cancer Res 2020
7
14


Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization.
Stephanie Lheureux, Zhongwu Lai, Brian A Dougherty, Sarah Runswick, Darren R Hodgson, Kirsten M Timms, Jerry S Lanchbury, Stan Kaye, Charlie Gourley, David Bowtell,[...]. Clin Cancer Res 2017
80
14

Genomic instability--an evolving hallmark of cancer.
Simona Negrini, Vassilis G Gorgoulis, Thanos D Halazonetis. Nat Rev Mol Cell Biol 2010
14

Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.
Alcides Chaux, Roula Albadine, Antoun Toubaji, Jessica Hicks, Alan Meeker, Elizabeth A Platz, Angelo M De Marzo, George J Netto. Am J Surg Pathol 2011
116
14

p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation.
A R Pettitt, P D Sherrington, G Stewart, J C Cawley, A M Taylor, T Stankovic. Blood 2001
198
14

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.
Paz Polak, Jaegil Kim, Lior Z Braunstein, Rosa Karlic, Nicholas J Haradhavala, Grace Tiao, Daniel Rosebrock, Dimitri Livitz, Kirsten Kübler, Kent W Mouw,[...]. Nat Genet 2017
267
14

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
Marilyn M Li, Michael Datto, Eric J Duncavage, Shashikant Kulkarni, Neal I Lindeman, Somak Roy, Apostolia M Tsimberidou, Cindy L Vnencak-Jones, Daynna J Wolff, Anas Younes,[...]. J Mol Diagn 2017
735
14

Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
Emilie Lalonde, Adrian S Ishkanian, Jenna Sykes, Michael Fraser, Helen Ross-Adams, Nicholas Erho, Mark J Dunning, Silvia Halim, Alastair D Lamb, Nathalie C Moon,[...]. Lancet Oncol 2014
208
14

Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents.
Ádám Póti, Hella Gyergyák, Eszter Németh, Orsolya Rusz, Szilárd Tóth, Csenger Kovácsházi, Dan Chen, Bernadett Szikriszt, Sándor Spisák, Shunichi Takeda,[...]. Genome Biol 2019
48
14


Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung,[...]. Clin Cancer Res 2016
438
14

Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy.
Pedro Isaacsson Velho, David Lim, Hao Wang, Jong Chul Park, Harsimar B Kaur, Fawaz Almutairi, Michael A Carducci, Samuel R Denmeade, Mark C Markowski, William B Isaacs,[...]. JCO Precis Oncol 2019
14
14

PARP inhibitors in prostate cancer: time to narrow patient selection?
Mark C Markowski, Emmanuel S Antonarakis. Expert Rev Anticancer Ther 2020
3
33

Functional assays for analysis of variants of uncertain significance in BRCA2.
Lucia Guidugli, Aura Carreira, Sandrine M Caputo, Asa Ehlen, Alvaro Galli, Alvaro N A Monteiro, Susan L Neuhausen, Thomas V O Hansen, Fergus J Couch, Maaike P G Vreeswijk. Hum Mutat 2014
79
14

Nitrogen chlorosis in blue-green algae.
M M Allen, A J Smith. Arch Mikrobiol 1969
205
14

Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations.
Zsofia Sztupinszki, Miklos Diossy, Marcin Krzystanek, Judit Borcsok, Mark M Pomerantz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, István Csabai, Matthew L Freedman,[...]. Clin Cancer Res 2020
32
14

Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Timothy C Greiner, Chiranjib Dasgupta, Vincent V Ho, Dennis D Weisenburger, Lynette M Smith, James C Lynch, Julie M Vose, Kai Fu, James O Armitage, Rita M Braziel,[...]. Proc Natl Acad Sci U S A 2006
109
14

Etiologic Index - A Case-Only Measure of BRCA1/2-Associated Cancer Risk.
Raymond Hughley, Rosa Karlic, Himanshu Joshi, Clare Turnbull, William D Foulkes, Paz Polak. N Engl J Med 2020
9
14

PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
Carlos L Morais, Mehsati Herawi, Antoun Toubaji, Roula Albadine, Jessica Hicks, George J Netto, Angelo M De Marzo, Jonathan I Epstein, Tamara L Lotan. Prostate 2015
25
14

Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
Kirsten M Timms, Victor Abkevich, Elisha Hughes, Chris Neff, Julia Reid, Brian Morris, Saritha Kalva, Jennifer Potter, Thanh V Tran, Jian Chen,[...]. Breast Cancer Res 2014
206
14

The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.
Britta Weigelt, Rui Bi, Rahul Kumar, Pedro Blecua, Diana L Mandelker, Felipe C Geyer, Fresia Pareja, Paul A James, Fergus J Couch, Diana M Eccles,[...]. J Natl Cancer Inst 2018
61
14

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
14

Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
Jai N Patel, Ioana Braicu, Kirsten M Timms, Cara Solimeno, Placede Tshiaba, Julia Reid, Jerry S Lanchbury, Silvia Darb-Esfahani, Mahrukh K Ganapathi, Jalid Sehouli,[...]. Br J Cancer 2018
22
14

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.